Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
AVON ORGANIC ADCOCK INGRAM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
AVON ORGANIC Mar-23 |
ADCOCK INGRAM Jun-14 |
AVON ORGANIC/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 7 | 321 | - | |
Low | Rs | 2 | 232 | - | |
Sales per share (Unadj.) | Rs | 0 | 95.5 | - | |
Earnings per share (Unadj.) | Rs | -2.3 | -24.1 | - | |
Cash flow per share (Unadj.) | Rs | -0.6 | -20.0 | - | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -53.7 | 75.0 | - | |
Shares outstanding (eoy) | m | 23.83 | 168.78 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 2.9 | - | |
Avg P/E ratio | x | -1.8 | -11.5 | 16.0% | |
P/CF ratio (eoy) | x | -6.9 | -13.9 | 49.8% | |
Price / Book Value ratio | x | -0.1 | 3.7 | -2.2% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 102 | 46,656 | 0.2% | |
No. of employees | `000 | NA | 4.3 | 0.0% | |
Total wages/salary | Rs m | 2 | 2,928 | 0.1% | |
Avg. sales/employee | Rs Th | 0 | 3,756.2 | - | |
Avg. wages/employee | Rs Th | 0 | 682.1 | - | |
Avg. net profit/employee | Rs Th | 0 | -946.5 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 16,125 | 0.0% | |
Other income | Rs m | 0 | 113 | 0.1% | |
Total revenues | Rs m | 0 | 16,238 | 0.0% | |
Gross profit | Rs m | -15 | -2,794 | 0.5% | |
Depreciation | Rs m | 41 | 696 | 5.9% | |
Interest | Rs m | 0 | 437 | 0.0% | |
Profit before tax | Rs m | -56 | -3,814 | 1.5% | |
Minority Interest | Rs m | 0 | -11 | -0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 238 | 0.0% | |
Profit after tax | Rs m | -56 | -4,063 | 1.4% | |
Gross profit margin | % | 0 | -17.3 | - | |
Effective tax rate | % | 0 | -6.2 | 0.0% | |
Net profit margin | % | 0 | -25.2 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 377 | 11,810 | 3.2% | |
Current liabilities | Rs m | 1,659 | 6,645 | 25.0% | |
Net working cap to sales | % | 0 | 32.0 | - | |
Current ratio | x | 0.2 | 1.8 | 12.8% | |
Inventory Days | Days | 0 | 111 | - | |
Debtors Days | Days | 0 | 124 | - | |
Net fixed assets | Rs m | 376 | 6,884 | 5.5% | |
Share capital | Rs m | 238 | 75 | 318.2% | |
Net worth | Rs m | -1,280 | 12,657 | -10.1% | |
Long term debt | Rs m | 327 | 4,448 | 7.3% | |
Total assets | Rs m | 753 | 23,909 | 3.2% | |
Interest coverage | x | 0 | -7.7 | - | |
Debt to equity ratio | x | -0.3 | 0.4 | -72.6% | |
Sales to assets ratio | x | 0 | 0.7 | 0.0% | |
Return on assets | % | -7.4 | -15.2 | 48.6% | |
Return on equity | % | 4.3 | -32.1 | -13.5% | |
Return on capital | % | 5.8 | -19.8 | -29.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 9 | 1,376 | 0.6% | |
From Investments | Rs m | NA | -423 | -0.0% | |
From Financial Activity | Rs m | -9 | 4,037 | -0.2% | |
Net Cashflow | Rs m | 0 | 4,990 | 0.0% |
Compare AVON ORGANIC With: MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Compare AVON ORGANIC With: LASA SUPERGENERICS FABINO LIFE BIOFIL CHEMICALS SURYA PHARMA ALBERT DAVID
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.